
JPXHealthcareBiotechnology
Latest quote
¥142
−¥4.00 · -2.74%
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Latest quote
¥142
−¥4.00 · -2.74%
Regular session · JST · Market data may be delayed.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Day range
Current ¥142
52-week range
Current ¥142
Regular session · JST · Market data may be delayed.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Day range
Current ¥142
52-week range
Current ¥142
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5M JPY | 7.59M JPY | 316.82M JPY | 625.78M JPY | 100.73M JPY |
| Cost of goods sold | — | 195K JPY | 2.26M JPY | 7.08M JPY | 22.9M JPY |
| Gross profit | 5M JPY | 7.39M JPY | 314.56M JPY | 618.71M JPY | 77.83M JPY |
| Research and development | 360.88M JPY | 579.88M JPY | 646.71M JPY | 334.8M JPY | 514.83M JPY |
| Selling, general, and administrative | 441.38M JPY | 496.7M JPY | 443.25M JPY | 390.25M JPY | 330.52M JPY |
| Operating expenses | 802.25M JPY | 1.08B JPY | 1.09B JPY | 725.05M JPY | 845.34M JPY |
| Interest income | 6.4M JPY | 609K JPY | 44K JPY | 55K JPY | 80K JPY |
| Operating income | −797.25M JPY | −1.07B JPY | −775.39M JPY | −106.35M JPY | −767.51M JPY |
| Net income | −793.54M JPY | −964.46M JPY | −1.13B JPY | −386.62M JPY | −795.04M JPY |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.